These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20133495)

  • 1. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.
    Hoskins MH; Leleiko RM; Ramos JJ; Sola S; Caneer PM; Khan BV
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):47-52. PubMed ID: 20133495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes.
    Carrillo X; Curós A; Muga R; Serra J; Sanvisens A; Bayes-Genis A
    Eur Heart J; 2011 May; 32(10):1244-50. PubMed ID: 21266375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
    Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
    Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006.
    Wilbert-Lampen U; Nickel T; Leistner D; Güthlin D; Matis T; Völker C; Sper S; Küchenhoff H; Kääb S; Steinbeck G
    J Am Coll Cardiol; 2010 Feb; 55(7):637-42. PubMed ID: 20170788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome].
    Wang XM; Li Y; Huang C; Zhang RH; Guo HT; Chen H; Wang HC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):149-51. PubMed ID: 16027783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?
    Page RL; Utz KJ; Wolfel EE
    Ann Pharmacother; 2007 Dec; 41(12):2008-13. PubMed ID: 17956961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Beta blockade improve outcome after injury by modulating inflammatory profiles?
    Friese RS; Barber R; McBride D; Bender J; Gentilello LM
    J Trauma; 2008 Apr; 64(4):1061-8. PubMed ID: 18404076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.
    Yan JC; Zhu J; Gao L; Wu ZG; Kong XT; Zong RQ; Zhan LZ
    Clin Chim Acta; 2004 May; 343(1-2):155-9. PubMed ID: 15115688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass?
    Fansa I; Gol M; Nisanoglu V; Yavas S; Iscan Z; Tasdemir O
    Med Sci Monit; 2003 Apr; 9(4):PI30-6. PubMed ID: 12709682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the hemodynamic effects of labetalol and sodium nitroprusside in patients undergoing carotid endarterectomy.
    Geniton DJ
    AANA J; 1990 Aug; 58(4):281-7. PubMed ID: 2399780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between inflammation and thrombosis in acute coronary syndrome.
    Lytvyn OI; Kopitsa MP; Petyunina OV
    Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.